New statistics recently released by the American Cancer Society indicate that screening for breast cancer as dropped 6% (2.13 million), while screening for cervical cancer is done by 11% (4.47 million) in the United States. Believed to be the first study to evaluate the impact of the COVID-19 pandemic using population-based data, the findings further revealed a 17% drop among Hispanic women undergoing cervical cancer screening, while 27% fewer Asian/Pacific women attended breast cancer screening, "the largest drop for any race."
To read more about this study, click here.
No comments:
Post a Comment